Theratechnologies Inc (TSE:TH) was upgraded by equities research analysts at National Bank Financial from a “sector perform market weight” rating to an “outperform market weight” rating in a report released on Thursday.

Shares of Theratechnologies (TSE:TH) opened at 3.41 on Thursday. The stock’s 50 day moving average price is $3.15 and its 200-day moving average price is $2.72. Theratechnologies has a 12 month low of $1.26 and a 12 month high of $3.74. The firm has a market capitalization of $224.83 million and a PE ratio of 852.50.

About Theratechnologies

Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company’s product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

Receive News & Stock Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related stocks with our FREE daily email newsletter.